StockCanadaNasdaqGS

ABCL

AbCellera Biologics Inc.

Healthcare · Biotechnology

11.05USD

-0.3900 (-3.41%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 11.05

P/E—

Dvd Ind Yld—

P/B4.00

P/S54.1

Curr EV/T12M EBITDA-15.5

Mkt Cap (USD)3.6B

Curr EV (USD)3.1B

Per Share Data

EPS T12M-0.54

DPS—

Bk Val Per Sh2.92

Rev/Sh0.22

Cash/Sh1.76

Curr Shares Out324.0M

FCF/Sh-0.39

Cash Flow Analysis

P/CF-37.7

Curr P/FCF-29.9

CF/NI0.6

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales-143.5%

Eff Interest Rate—

Growth Potential

Dil EPS 1Y Gr10.9%

Cap 1Y Gr-8.4%

BPS 1Y Gr-9.8%

R&D To Sales298.9%

Retention Rate100.0%

Rev 1Y Gr160.6%

FCF 1Y Gr6.9%

Assets 1Y Gr-0.3%

Profitability

EBITDA-0.2B

EBIT-0.2B

Operating Margin-340.3%

Pretax Margin-297.4%

Net Margin-248.8%

ROA-12.2%

ROE-17.3%

ROC-18.3%

Asset Turnover0.05

Structure

Current Ratio12.77

Quick Ratio11.23

Debt/Assets10.4%

Debt/Com Eq15.1%

Net Debt/EBITDA-0.08

Tot Debt/Capital13.1%

Gross Margin-198.9%

EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.